Supreme Cannabis Appoints Permanent CEO

The Supreme Cannabis Company (TSX: FIRE) this morning announced a permanent replacement for the CEO role following the departure of Nav Dhaliwal in early January from the firm. Beena Goldenberg, former CEO of Hain-Celestial Canada, has been appointed as Supreme’s new CEO and President of the company.

With over thirty years experience in the consumer packaged goods industry, Goldenberg has spent the last 15 years in leadership roles for Hain Canada, where she had most recently served as CEO since 2016. Hain Canada is the Canadian subsidiary of The Hain Celestial Group, an organic-product focused CPG company which notably was founded by Irwin Simon, the current CEO of Aphria Inc (TSX: APHA) (NYSE: APHA).

Goldenberg will be taking the reins from that of interim CEO Colin Moore, who will remain as a director for the firm as well as act as an adviser to Goldenberg until the end of July. Goldenberg has also been appointed as a director of the board.

“The Board and I are thrilled to welcome Beena Goldenberg to lead the Company as our new President and CEO. Beena is a proven, entrepreneurial leader in the Canadian CPG sector who will apply her passion and expertise in marketing and manufacturing to Supreme Cannabis’ brands and operations and capture the vast opportunities within the Canadian and global cannabis industries. Supreme Cannabis continues to attract top talent with its compelling position in the cannabis space. In this time of elevated global uncertainty, the Company is particularly fortunate to move forward with a proven leader in place.”

Supreme Cannabis’ Board Chairman, Michael La Brier

The Supreme Cannabis Company last traded at $0.28 on the TSX.

Information for this analysis was found via Sedar and Supreme Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

2 thoughts on “Supreme Cannabis Appoints Permanent CEO

Leave a Reply